Astellas Pharma reported JPY88.87B in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Astellas Pharma 4503:JP Y 88870M 29955M
Chugai Pharma 4519:JP Y 79823M 34601M
Daiichi Sankyo 4568:JP Y 74798M 14032M
Eisai 4523:JP Y 47404M 3334M
Kyowa Hakko Kirin 4151:JP Y 21221M 938M
M3 2413:JP 23.67B 770M
Otsuka Holdings 4578:JP Y 147947M 21607M
Shionogi 4507:JP Y 12945M 2617M
Sumitomo Dainippon 4506:JP Y 46056M 6764M
Takeda 4502:JP Y 292882M 15498M
Terumo 4543:JP Y 89321M 3073M